Salomon & Ludwin’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.7K Buy
880
+211
+32% +$8.85K ﹤0.01% 512
2026
Q1
$21.6K Buy
669
+34
+5% +$1.26K ﹤0.01% 1029
2025
Q4
$27.7K Sell
635
-1
-0.2% -$40 ﹤0.01% 657
2025
Q3
$22.9K Buy
+636
New +$18.2K ﹤0.01% 735

Other funds holding VCYT

Salomon & Ludwin's VCYT Position: Q2 2026 in Review

Salomon & Ludwin increased its Veracyte (VCYT) stake by 32% in Q2 2026, buying an estimated $8.85K and bringing the position to 880 shares worth $52.7K. The position accounts for ﹤0.01% of the portfolio, ranked #512.

Salomon & Ludwin first reported a position in VCYT in Q3 2025 and has held it in 4 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Salomon & Ludwin held 880 shares of Veracyte worth $52.7K as of Q2 2026.
  • Salomon & Ludwin bought 211 Veracyte shares in Q2 2026, an estimated $8.85K.
  • Veracyte made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #512 holding.
  • Salomon & Ludwin first reported a position in Veracyte in Q3 2025 and has held it in 4 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.